FindTrial
Sign In

Understanding of vitiligo (skin disease).

Interrogation of Vitiligo Genesis â?? Cellular and Molecular analysis through iPSC.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013393
Enrollment
100
Registered
2018-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vitiligo(Skin Disorder)

Interventions

None listed

Sponsors

Dr K Satyamoorthy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case: Age and sex-matched participants with vitiligo disease and have not undergone treatment for the past 3 months are included in this study. Control: Age and sex matched participants without vitiligo and any other autoimmune disorder.

Exclusion criteria

Exclusion criteria: Case: Patients who have undergone treatment for past 3 months and participants with other clinical conditions are excluded from the study. Control: Patients with vitiligo or any other autoimmune disorder.

Design outcomes

Primary

MeasureTime frame
Identification of variants.Timepoint: 3years—

Secondary

MeasureTime frame
Association of variants with the skin disorder Vitiligo.Timepoint: 3 years—

Countries

India

Contacts

Public ContactDr Sanjiban Chakrabarthy

Kasturba Medical College, Manipal

jenny.rao@manipal.edu9845292640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026